Development

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Articles

The generic-drug company Actavis (Hafnarfjordur, Iceland) is considering acquiring a 51% stake in the biopharmaceutical company BioPartners Holdings (Barr, Switzerland) from Bioton, a Polish biotechnology company.

Actavis Signals Interest in Biosimilars Market

Pfizer to Acquire FoldRx; Protalix Appoints COO; And More.

Week of Sept. 6, 2010: Company and People Notes: Pfizer to Acquire FoldRx; Protalix Appoints COO; And More.

The Society for Chemical Manufacturers and Affiliates (SOCMA) issued recommendations relating to disclosure of confidential business information (CBI) in response to Environmental Protection Agency's (EPA) decision to limit CBI claims on chemical identity under the Toxic Substances Control Act (TSCA).

SOCMA Engages EPA on Disclosure Requirements for Confidential Business Information

Company and People Notes: Lonza Acquired Vivante; PPD Appoints VP of Quality Management; And More.

Week of Aug. 30, 2010: Company and People Notes: Lonza Acquires Vivante; PPD Appoints VP of Quality Management; And More.

A look at why Brazil revised its GMP standards and how the changes will affect the local pharmaceutical industry.

Report from Brazil September 2010

Pharmaceutical Technology gains insight into approaches for producing aromatic amines.

Technical Forum: Small-Molecule Synthesis

Michelle Hoffman, editorial director of Pharmaceutical Technology.

New data provide insight into pharma-industry professionals' daily lives.

Survey Says...

The current trend in the pharmaceutical industry for the manufacture of small-molecule therapeutic agents is moving toward continuous flow processes. This article is part of a special issue on APIs.

Contract Manufacturing and Continuous Flow Reactor Technology for Early-Stage Drug Development

The author presents recent developments in simulated moving-bed chromatography in production of active pharmaceutical ingredients and intermediates. This article is part of a special issue on APIs.

Evolution of Continuous Chromatography: Moving Beyond Chiral Separations

The author explains the background behind the excipient pedigree and how to implement its use.

Ingredients